Skip to content

Science Museum Group

Coronavirus: The one-shot vaccine
By Roger Highfield

…not one but multiple vaccines – at least two RNA vaccines, three adenovirus vector-based vaccines, a protein-based vaccine and one inactivated virus vaccine. There are more, and the fact that…

Coronavirus: RNA to the rescue
By Roger Highfield

…March to co-develop and distribute a potential vaccine for Covid-19. Pfizer had been working with BioNTech for a few years prior to the COVID pandemic on RNA vaccines, notably an…

Coronavirus: how the UK backed vaccine winners
By Roger Highfield

…including US physician Dr Anthony Fauci and Vaccine Deployment Minister Nadhim Zahawi MP, this week discuss vaccine hesitancy, described as one of the greatest challenges facing the COVID-19 vaccine rollout,…

COVID vaccine to go on display
By Natasha McEnroe

…of COVID vaccine used in a mass immunisation programme anywhere in the world will join the Science Museum Group Collection As the mass immunisation programme unfolds, countless vaccine vials and…

Coronavirus: a revolutionary vaccine
By Roger Highfield

…We need to assess whether the vaccine can train the immune system to defend itself against COVID-19. We eagerly await when we can assess both the safety of the vaccine

Coronavirus: Trials of the Oxford vaccine
By Roger Highfield

The UK has become the first country in the west to approve a COVID-19 vaccine, the Pfizer/BioNTech vaccine, which has an efficacy of around 95 per cent, similar to another…

Coronavirus: The Moth Vaccine
By Roger Highfield

A technology that is used to manufacture a seasonal influenza vaccine is being adapted to create another kind of COVID-19 vaccine, one based on virus protein. All vaccines work the…

Coronavirus: Ending the pandemic
By Roger Highfield

…a particular challenge in creating a COVID-19 vaccine? It is always hard to create a vaccine but one particular challenge with coronavirus vaccines is the lack of good animal models…

Coronavirus: from antibodies to vaccines
By Roger Highfield

…adenovirus, that he developed. How is COVID-19 vaccine research going? Worldwide, more than 100 COVID-19 vaccines are under development according to the Coalition for Epidemic Preparedness Innovations (CEPI). They are…

Coronavirus: Exit strategies
By Roger Highfield

vaccine to combat the human immunodeficiency virus (fortunately AIDS is now a manageable chronic disease, thanks to drugs). Even so, there is optimism that a COVID-19 vaccine could take as…